Eva Brix, Lukas Prantl, Arash Momeni, Vanessa Brebant, Britta Kuehlmann, Norbert Heine, Niklas Biermann
Original article
The use of systemic prophylactic antibiotics to reduce surgical-site infection in esthetic breast surgery remains controversial, although the majority of surgeons prefer to utilize antibiotics to prevent infection. Nonetheless, postoperative acute and subclinical infection and capsular fibrosis are among the most common complications following implant-based breast reconstruction. After esthetic breast augmentation, up to 2.9% of women develop infection, with an incidence rate of 1.7% for acute infections and 0.8% for late infections.
Sign in or register for free to read the full article
